Literature DB >> 9621049

Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.

J F Kaye1, A M Lever.   

Abstract

The ability of human immunodeficiency virus types 1 (HIV-1) and 2 (HIV-2) to cross-package each other's RNA was investigated by cotransfecting helper virus constructs with vectors derived from both viruses from which the gag and pol sequences had been removed. HIV-1 was able to package both HIV-1 and HIV-2 vector RNA. The unspliced HIV-1 vector RNA was packaged preferentially over spliced RNA; however, unspliced and spliced HIV-2 vector RNA were packaged in proportion to their cytoplasmic concentrations. The HIV-2 helper virus was unable to package the HIV-1 vector RNA, indicating a nonreciprocal RNA packaging relationship between these two lentiviruses. Chimeric proviruses based on HIV-2 were constructed to identify the regions of the HIV-1 Gag protein conferring RNA-packaging specificity for the HIV-1 packaging signal. Two chimeric viruses were constructed in which domains within the HIV-2 gag gene were replaced by the corresponding domains in HIV-1, and the ability of the chimeric proviruses to encapsidate an HIV-1-based vector was studied. Wild-type HIV-2 was unable to package the HIV-1-based vector; however, replacement of the HIV-2 nucleocapsid by that of HIV-1 generated a virus with normal protein processing which could package the HIV-1-based vector. The chimeric viruses retained the ability to package HIV-2 genomic RNA, providing further evidence for a lack of reciprocity in RNA-packaging ability between the HIV-1 and HIV-2 nucleocapsid proteins. Inclusion of the p2 domain of HIV-1 Gag in the chimera significantly enhanced packaging.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621049      PMCID: PMC110391     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.

Authors:  S C Pettit; M D Moody; R S Wehbie; A H Kaplan; P V Nantermet; C A Klein; R Swanstrom
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

2.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  A short sequence upstream of the 5' major splice site is important for encapsidation of HIV-1 genomic RNA.

Authors:  H J Kim; K Lee; J J O'Rear
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

4.  Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR.

Authors:  N Morellet; H de Rocquigny; Y Mély; N Jullian; H Déméné; M Ottmann; D Gérard; J L Darlix; M C Fournie-Zaluski; B P Roques
Journal:  J Mol Biol       Date:  1994-01-07       Impact factor: 5.469

5.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

Authors:  A Lever; H Gottlinger; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.

Authors:  C Parolin; T Dorfman; G Palú; H Göttlinger; J Sodroski
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  T Dorfman; J Luban; S P Goff; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

Authors:  J Clever; C Sassetti; T G Parslow
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein.

Authors:  R D Berkowitz; S P Goff
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

10.  Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.

Authors:  J Dannull; A Surovoy; G Jung; K Moelling
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  59 in total

1.  Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

Authors:  C Liang; L Rong; Y Quan; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  The TY3 Gag3 spacer controls intracellular condensation and uncoating.

Authors:  Kristina Clemens; Liza Larsen; Min Zhang; Yurii Kuznetsov; Virginia Bilanchone; Arlo Randall; Adam Harned; Rhonda Dasilva; Kunio Nagashima; Alexander McPherson; Pierre Baldi; Suzanne Sandmeyer
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

4.  A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA.

Authors:  Jean-Marc Lanchy; John D Ivanovitch; J Stephen Lodmell
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

5.  HIV-1 RNA genome dimerizes on the plasma membrane in the presence of Gag protein.

Authors:  Jianbo Chen; Sheikh Abdul Rahman; Olga A Nikolaitchik; David Grunwald; Luca Sardo; Ryan C Burdick; Sergey Plisov; Edward Liang; Sheldon Tai; Vinay K Pathak; Wei-Shau Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

6.  Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region.

Authors:  Helga Bjarnadottir; Bjarki Gudmundsson; Janus Gudnason; Jon J Jonsson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

7.  An extended stem-loop 1 is necessary for human immunodeficiency virus type 2 replication and affects genomic RNA encapsidation.

Authors:  Jean-Marc Lanchy; J Stephen Lodmell
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

8.  In vitro expression of the HIV-2 genomic RNA is controlled by three distinct internal ribosome entry segments that are regulated by the HIV protease and the Gag polyprotein.

Authors:  Emiliano P Ricci; Cécile H Herbreteau; Didier Decimo; Andreas Schaupp; Siddhartha A K Datta; Alan Rein; Jean-Luc Darlix; Théophile Ohlmann
Journal:  RNA       Date:  2008-05-21       Impact factor: 4.942

9.  Determining the frequency and mechanisms of HIV-1 and HIV-2 RNA copackaging by single-virion analysis.

Authors:  Kari A Dilley; Na Ni; Olga A Nikolaitchik; Jianbo Chen; Andrea Galli; Wei-Shau Hu
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

10.  Accuracy estimation of foamy virus genome copying.

Authors:  Kathleen Gärtner; Tatiana Wiktorowicz; Jeonghae Park; Ayalew Mergia; Axel Rethwilm; Carsten Scheller
Journal:  Retrovirology       Date:  2009-04-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.